Key takeaways
Insulin glulisine (Apidra) and insulin lispro (Admelog) are both fast-acting insulins used to manage blood sugar levels in people with Type 1 and Type 2 diabetes. They are both injected under the skin and can be used with insulin pumps. However, there are some differences between the two. Insulin glulisine (Apidra) is approved for use in people with Type 1 diabetes aged 4 years and older, while insulin lispro (Admelog) is approved for those aged 3 years and older. Apidra can be injected within 15 minutes before or 20 minutes after a meal, whereas Admelog should be injected within 15 minutes before or right after a meal. Both medications can cause low blood sugar and weight gain. Additionally, Apidra can be mixed with NPH insulin, while Admelog should not be mixed with other insulins. Both medications require careful monitoring of blood sugar levels and should not be shared with others to prevent infections.
